For more than a century, the American Association of Cancer Research has held its annual meeting and this weekend will kick off the 101st event in Washington, DC, which is being held April 17-21, 2010. Many pharmaceutical and biotechnology companies will be presenting new data and approximately 6,300 abstracts will be discussed in...
Read More »
Posts Tagged ‘ Bayer ’
Allos Therapeutics
ALTH
AMAG
AMAG Pharmaceuticals
American Society of Clinical Oncology
Amgen
AMGN
Amicus Therapeutics
AMLN
ASCO
Astellas Pharma
BIIB
Biogen Idec
biotech
biotechnology
BMY
CELG
Celgene
CEPH
Cephalon
CYCC
Cyclacel Pharmaceuticals
Dendreon
DNDN
FOLD
GENZ
GlaxoSmithKline
GSK
JNJ
Johnson & Johnson
life sciences
LLY
monoclonal antibodies
OSIR
Osiris Therapeutics
PFE
Pfizer
prostate cancer
Provenge
roche
Sanofi-Aventis
Seattle Genetics
SGEN
SNY
Soligenix
Cyclin-dependent Cancer Confab Preview
Biotech Deal Activity Declines…The Pause that Refreshes?
* MD Becker Partners reporting live from the JP Morgan Healthcare Conference This week, nearly 6,500 registrants gathered in San Francisco, California for the JP Morgan Healthcare Conference to hear 25-minute presentations from 338 life science companies. For industry executives and investors, the annual event serves as a good barometer for the rest of...
Read More »







